Pharmacologic management of keratomycoses

Surv Ophthalmol. 1988 Nov-Dec;33(3):178-88. doi: 10.1016/0039-6257(88)90086-0.

Abstract

Fungal corneal infections can be very difficult to treat. An evolving understanding of the pharmacology of the currently available antifungal agents has led to improved medical treatment of the keratomycoses. The pharmacology, pharmacokinetics, spectrum of activity and toxicity of these agents is reviewed and promising new antifungal compounds and modes of treatment are discussed.

Publication types

  • Review

MeSH terms

  • Antifungal Agents / adverse effects
  • Antifungal Agents / pharmacology
  • Antifungal Agents / therapeutic use*
  • Chemical Phenomena
  • Chemistry
  • Corneal Diseases / drug therapy*
  • Humans
  • Imidazoles / therapeutic use
  • Molecular Structure
  • Mycoses / drug therapy*
  • Polyenes / therapeutic use
  • Pyrimidines / therapeutic use

Substances

  • Antifungal Agents
  • Imidazoles
  • Polyenes
  • Pyrimidines